Study S000969

Clinical Efficacy and Safety of Liraglutide in the Treatment of Obesity Combined With Metabolism-associated Fatty Liver Disease (MAFLD)

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT06501326
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE4
Masking: QUADRUPLE
Status: UNKNOWN
Enrollment: 102
Start: 2023-11-01
Primary completion: 2024-10-31
Lead sponsor: Affiliated Hospital of Nantong University
Conditions: Non-alcoholic Fatty Liver Disease; Obesity
Interventions: DRUG:Liraglutide; DRUG:Orlistat
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

Body weight [Three months]
FABP4 [Three months]
BMI [Three months]
lipid indices [Three months]
LSM [Three months]
CAP [Three months]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.